Rajiv Panikkar

Effectiveness of a Cardiovascular Health Electronic Health Record Application for Cancer Survivors in Community Oncology Practice: Results From WF-1804CD

Emily V. Dressler, Heidi D. Klepin, Simon J. Craddock Lee, Brian J. Wells et autres

us (code pays fourni par la source)

SIOG2024-4-P-088 Patient-level predictors of geriatric assessment-driven referral to occupational or physical therapy for older adults with advanced cancer

Lindsey L. Page, Marielle Jensen‐Battaglia, Brennan Parmelee Streck, R. Tylock et autres

Pneumologische Onkologie Tumor Treating Fields (TTFields) therapy with standard systemic therapy in metastatic non-small cell lung cancer following progression on or after platinum-based therapy: global randomized, pivotal (phase 3) LUNAR study

Richard Greil, Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau et autres

at, us, in, pl, cn, es, cz, hr, rs, be, nl, ch, Zambie, Afrique du Sud, Tanzanie, Ouganda, ca (code pays fourni par la source)

TTFields (Tumor Treating Fields) associés au traitement standard dans les cancers du poumon non à petites cellules métastatiques en progression après platine : étude internationale, randomisée de phase 3 LUNAR

Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, L. Zhang et autres

us, pl, cn, es, cz, rs, nl, it, ch (code pays fourni par la source)

Tumor Treating Fields (TTFields) Therapy with Standard of Care in Metastatic Non-small Cell Lung Cancer Following Progression on or after Platinum Therapy: Global, Randomized, Pivotal Phase 3 LUNAR Study

Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, L. Zhang et autres

us, pl, cn, es, cz, rs, be, nl, it, ch (code pays fourni par la source)

OA22.05 TTFields and Immune-Checkpoint Inhibitor in Metastatic Non-Small Cell Lung Cancer: PD-L1 Subgroups in the Phase 3 LUNAR Study

Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, L. Zhang et autres

us, pl, cn, es, cz, rs, be, nl, it, ch, at, sk, ca (code pays fourni par la source)

607 TTFields therapy with an immune checkpoint inhibitor in metastatic non-small cell lung cancer (mNSCLC) with progression on/after platinum-based therapy: histology subgroups in the pivotal LUNAR study

Jeffrey P. Ward, Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau et autres

us, pl, cn, es, cz, rs, be, nl, it, ch, at, sk, ca (code pays fourni par la source)

1418P Impact of TTFields therapy on global and functional health-related quality of life (HRQoL) in metastatic non-small cell lung cancer (mNSCLC) from the pivotal LUNAR study

Rupesh Kotecha, Ticiana Leal, R. Raumlau, L. Zhang et autres

us, pl, cn, es, cz, rs, be, nl, ch, at (code pays fourni par la source)

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

Benjamin Besse, Enriqueta Felip, Rosario García Campelo, Manuel Cobo et autres

fr, es, us, it, de, il, pl (code pays fourni par la source)

Radiation Therapy in the Last Month of Life: Association With Aggressive Care at the End of Life

Mellar P. Davis, Erin Vanenkevort, Amanda Young, Mark Wojtowicz et autres

us (code pays fourni par la source)

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, Li Zhang et autres

us, pl, cn, es, cz, rs, be, nl, it, ch, at, ca (code pays fourni par la source)

Tumor Treating Field (TTFields) therapy with standard of care (SOC) in metastatic non-small cell lung cancer (mNSCLC) following platinum failure: Randomized, phase 3 LUNAR study.

Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, Zhang Li et autres

us, pl, cn, es, cz, rs, be, nl, it, ch (code pays fourni par la source)